CN106362095A - Traditional Chinese medicine composition capable of treating breast hyperplasia - Google Patents

Traditional Chinese medicine composition capable of treating breast hyperplasia Download PDF

Info

Publication number
CN106362095A
CN106362095A CN201610967691.1A CN201610967691A CN106362095A CN 106362095 A CN106362095 A CN 106362095A CN 201610967691 A CN201610967691 A CN 201610967691A CN 106362095 A CN106362095 A CN 106362095A
Authority
CN
China
Prior art keywords
grams
radix
rhizoma
medicament composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610967691.1A
Other languages
Chinese (zh)
Inventor
白文娟
尹艳玲
张春莲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610967691.1A priority Critical patent/CN106362095A/en
Publication of CN106362095A publication Critical patent/CN106362095A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/902—Sparganiaceae (Bur-reed family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicament composition capable of treating cyclomastopathy and belongs to the field of medicine. The medicament composition is characterized by being prepared from the following raw materials by weight: 150g of fruit of trichosanthes kirilowii Maxim, 150g of raw oysters, 60g of pangolin, 120g of rhizoma corydalis processed with vinegar, 100g of spica prunellae, 100g of thunberg fritillary bulb, 120g of seaweed, 80g of radix bupleuri, 80g of fructus corni, 120g of radix rehmanniae preparata, 80g of radix asparagi, 80g of rhizoma sparganii, 80g of rhizoma zedoariae, 80g of tangerine seeds, 80g of pinellia tuberifera, 100g of radix angelica sinensis, 80g of herba leonuri, 80g of rhizoma corydalis, 30g of mastic, 30g of myrrh, 60g of licorice root, 80g of white peony root, 80g of radix curcumae, 80g of radix astragali, 80g of Yunnan poria cocos, 80g of white mustard seeds, 80g of cow soapwortseed and 80g of muscardine silkworm. The use method and dosage of the medicament composition are as follows: the raw material based on the above proportion are used for one course of treatment and are about 2400g after being pulverized into powder. 40g of the medicament composition is taken after meal once respectively each morning and evening; after taking the medicament composition for one course of treatment, a mild patient can be healed; after taking the medicament composition for 2-4 courses of treatment, a critical patient can be healed.

Description

A kind of pharmaceutical composition treating cyclomastopathy
Technical field
The invention belongs to medical domain is and in particular to a kind of pharmaceutical composition treating cyclomastopathy.
Background technology
The cyclomastopathy traditional Chinese medical science claims nodules of the breast, is women of child-bearing age's cystic hyperplasia of breast sickness rate highest disease, sends out well age 30-50 year, Especially common with the unsuccessful person of feelings will.It shows themselves in that the invisible lump occurring in breast, and lump often simultaneously or sequentially betides bilateral Breast, quality is medium or matter is not firmly hard, and not of uniform size, shape is indefinite, and border is not very clear, with skin adhesion.Lump can show For piece block-type, nodular type, mixed type with diffuse type, it is scattered in whole breast or is confined at one, breast often feels distending pain at ordinary times, There are twinge or tractive pain, Chang Yue premenstrual 3-4 day aggravates, mitigates through row pain, or symptom changes with anxious state of mind, and pain is very Person can not touch, and the course of disease is chronic, often delays the several years, before and after menopause, symptom often mitigates or dies away, and nipple can sometimes for patient Overflow yellow green, brown or bloody fluid.
Nodules of the breast presses Chinese medical discrimination, is broadly divided into following four types:
1. this kind of clinic of liver qi-stagnation is more common, is common in adolescence or course of disease shorter one.Card is shown in that melancholy is joyless, vexed easy Hot-tempered, both sides distending pain of the breast, can lay one's hand on and arsine block, its lump often fluctuates and growth and decline with feelings will, often in premenstrual nipple, distending pain of the breast more Very, through after can alleviate, have two side of body feeling of distension and oppression concurrently, deficiency of QI with disinclination to talk, be apt to sigh, dim gas frequency is made.Pale tongue, white and thin fur, arteries and veins carrys out string Thin doctor's ` education network is collected and is arranged.
2. show as emaciated physique this kind of patient of hyperactivity of fire caused by deficiency of YIN, lump in breast is multiple more, distending pain and with burn feeling, simultaneously visible Dizziness and tinnitus, hectic fever in the afternoon, lassitude, fidgets due to deficiency is insomnia, exciting irritability, xerostomia or bitter taste, disorder of menstrual cycle, and urine is short of, greatly Dry stool is secret.Red tongue, tongue is few, and pulse condition is counted accurately.
3. disharmony of Chong and Conception Channels this kind of be more common in menopausal women.Distending pain of the breast or dull pain, caking size and pain etc. in breast Symptom often substantially increases in premenstrual, through after significantly mitigate.Often with lustreless complexion, soreness of waist and knee, neurolysises, night sleeps disintoxicated, the moon Through disorder, the few color of amount is light, even amenorrhea.Pale tongue with white fur, pulse condition is thin and delicate.
4. the phlegm-blood stasis course of disease that stagnates is longer, and patient's chest prolonged difficulty of luming disappears, distending pain or twinge, and the lump quality touched is harder, Mobility is poor.Patient's abundant expectoration at ordinary times, matter is sticky, irritable, insomnia and dreamful sleep, exacerbation of symptoms during anxious state of mind, few through row amount, Color is dim, has clot, abdominal pain during menstruation concurrently.Body of the tongue is dim red or has petechia, and arteries and veins comes carefully puckery.
Chinese traditional treatment is primarily now leaned in the treatment of cyclomastopathy.The main method for the treatment of of the traditional Chinese medical science divides method for the treatment of for oral administration and external application method for the treatment of. External application method for the treatment of is fixed because of uncertain therapeutic efficacy, treats inconvenient and rarely has people to use.The traditional Chinese medical science takes method for the treatment of determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs: dispersing the stagnated live-QI to relieve the stagnation of QI, YIN nourishing orally Heat clearing away, regulating thoroughfare and controlling vessel, dissipating phlegm and resolving masses.Ripe prescription is very many, and representing has Xiao Yao Lou Bei San, RUPIXIAO etc..But because of modern society Meeting women pressure is larger, and very many cyclomastopathy patients often do not reach satisfied therapeutical effect using conventional prescription, Relapse rate is made to show effect, treatment cycle is long, and costly, the misery brought to patient is larger.
Content of the invention
Present invention solves the technical problem that being: Chinese medicine or western medical treatment cyclomastopathy effect on driving birds is not good, Relapse rate Outbreak, treatment cycle is long, and costly, the misery brought to patient is larger.The plan method for the treatment of of the present invention is: depressed liver-energy dispersing and QI regulating, promoting blood circulation Blood stasis dispelling, hard masses softening and resolving, regulating thoroughfare and controlling vessel, removing heat-phlegm.
The technical solution used in the present invention is: a kind of pharmaceutical composition treating cyclomastopathy, it is characterized in that: by weight: 150 grams of Fructus Trichosanthis, 150 grams of Concha Ostreae, 60 grams of Squama Maniss, 120 grams of stir-baked RHIZOMA CORYDALIS with vinegar, 100 grams of Spica Prunellae, 100 grams of Bulbus Fritillariae Thunbergii, Sargassum 120 Gram, 80 grams of Radix Bupleuri, 80 grams of Fructus Corni, 120 grams of Radix Rehmanniae Preparata, 80 grams of Radix Asparagi, 80 grams of Rhizoma Sparganii, 80 grams of Rhizoma Curcumae, 80 grams of Semen Citri Reticulatae, the Rhizoma Pinelliae 80 Gram, 100 grams of Radix Angelicae Sinensis, 80 grams of Herba Leonuri, 80 grams of Rhizoma Corydalis, 30 grams of Olibanum, 30 grams of Myrrha, 60 grams of Radix Glycyrrhizae, the Radix Paeoniae Alba 80, Radix Curcumae 80, 80 grams of the Radix Astragali, PORIA from Yunnan of China 80, Semen Sinapis Albae 80,80 grams of Semen Vaccariae, 80 grams of Bombyx Batryticatus.
Usage and consumption: aforementioned proportion proportioning is a course for the treatment of medication, about 2400 grams of grind into powder.Take 40 grams daily, early Evening each sub-service, one after each meal.Disease the lighter one course for the treatment of can be fully recovered, and disease severe one serve on two to four courses for the treatment of and can fully recover.
In compositionss: liver controlling conveyance and dispersion, property happiness bar reaches and dislikes depression, therefore reuses Concha Ostreae bitter cold enter liver, and dispersing liver-energy is dived with suppressing the hyperactive liver Sun, is monarch drug.The liver belonging to wood, gram spleen soil, feelings will is not smooth, and it is unsuccessful to be willing to, the liver losing its smoothly moving state, functional activity of QI being not smooth, the stagnation of QI then stasis of blood；Then Rhizoma Corydalis Rope, Radix Curcumae, Olibanum, in Myrrha energy promoting the circulation of blood, the stagnation of QI, to reach the work(of promoting flow of QI and blood pain relieving, is the medicine of minister assistant.Stagnation of liver-QI gram violates spleen soil, fortune Change the dereliction of duty then turbid interior life of expectorant, liver spleen two is hindered, and meridians block, and phlegm and blood stasis are in breast, therefore use Squama Maniss, Rhizoma Sparganii, and it is logical that Rhizoma Curcumae breaks silt Network, dispersing swelling and dissipating binds；Fructus Trichosanthis, Sargassum, Bulbus Fritillariae Uninbracteatae, Rhizoma Corydalis, the Rhizoma Pinelliae, Semen Sinapis promoting the circulation of QI dissipating depression of QI, it is turbid descending that warm cold transformation expectorant leads expectorant.Another promoting blood circulation Middle residence is supported, the broken silt of promoting blood circulation and not energy consumption impairment of YIN blood, therefore with Radix Rehmanniae Preparata, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Asparagi adjusts liver, nourshing Yin and drynsessmoistening prescription with blood-nourishing.Again with The Radix Astragali, Fructus Corni convergence QI invigorating and righting, PORIA from Yunnan of China, Spica Prunellae eliminating dampness by diuresis to help the work(disappearing, invigorating spleen and reinforcing stomach, auxiliary healthy energy be Adjuvant drug.Radix Glycyrrhizae, Herba Leonuri, sweet slow and moisten, break, to delay all medicines, the power let out, thinking makes medicine, silt of can dispelling is newborn, depressed liver-energy dispersing and QI regulating gas row network Logical, no pain by smooth breath.
This beneficial effect of the invention is: carries out reasonable compatibility using the Chinese herbal medicine of traditional Chinese medicine, compatibility Chinese herbal medicine is equal For common medicine, medication is simple, advantage of lower cost, and certainly, side effect is less for curative effect.
Specific embodiment
By weight: by 150 grams of Fructus Trichosanthis, 150 grams of Concha Ostreae, 60 grams of Squama Maniss, 120 grams of stir-baked RHIZOMA CORYDALIS with vinegar, 100 grams of Spica Prunellae, 100 grams of Bulbus Fritillariae Thunbergii, 120 grams of Sargassum, 80 grams of Radix Bupleuri, 80 grams of Fructus Corni, 120 grams of Radix Rehmanniae Preparata, 80 grams of Radix Asparagi, 80 grams of Rhizoma Sparganii, Rhizoma Curcumae 80 grams, 80 grams of Semen Citri Reticulatae, 80 grams of the Rhizoma Pinelliae, 100 grams of Radix Angelicae Sinensis, 80 grams of Herba Leonuri, 80 grams of Rhizoma Corydalis, 30 grams of Olibanum, 30 grams of Myrrha, Radix Glycyrrhizae 60 grams, the Radix Paeoniae Alba 80, Radix Curcumae 80,80 grams of the Radix Astragali, PORIA from Yunnan of China 80, Semen Sinapis Albae 80,80 grams of Semen Vaccariae, 80 grams of Bombyx Batryticatus are pulverized About 2400 grams of end.Take 40 grams daily, sooner or later each sub-service, one after each meal, taking 60 days is a course for the treatment of, and disease the lighter one treats Journey can be fully recovered, and disease severe one serve on two to four courses for the treatment of and can fully recover.
Now with clinical treatment and 125 patients of follow-up observation situation illustrate said medicine effectiveness.125 patients All diagnosed by the clinical diagnosises of cyclomastopathy and the TCM Syndrome Type of nodules of the breast and syndrome, excluded other mastopathy, greatly Some patientss have done mammary gland color ultrasound and infrared inspection is all diagnosed as primary disease.Patient age 24 51 years old, average 37 ± 6 years old, disease The shortest person of journey is 2 months, and elder delays 21 years.Patient all will organize medicine by above-mentioned usage and consumption takes orally, after taking 1 course for the treatment of, controls More person 63, after taking 2 courses for the treatment of, healing person 32, after taking the 3-4 course for the treatment of, healing person 24.Take 4 course for the treatment of persons of having not yet fully recovered 6 Example, total cure rate is 95.2%.5 just dilute persons of having loose bowels occur in medication patient, may be cooler in the nature because of whole group prescription, take Dosage is excessive to be led to.4 stomach discomfort, may disappear the bad anti-of medicine for some removing heat-phlegm medicines in prescription and removing blood stasis Should.All toxic and side effects and untoward reaction in remaining patient.

Claims (1)

1. a kind of pharmaceutical composition treating cyclomastopathy, is characterized in that: by weight: 150 grams of Fructus Trichosanthis, 150 grams of Concha Ostreae, 60 grams of Squama Maniss, 120 grams of stir-baked RHIZOMA CORYDALIS with vinegar, 100 grams of Spica Prunellae, 100 grams of Bulbus Fritillariae Thunbergii, 120 grams of Sargassum, 80 grams of Radix Bupleuri, 80 grams of Fructus Corni, 120 grams of Radix Rehmanniae Preparata, 80 grams of Radix Asparagi, 80 grams of Rhizoma Sparganii, 80 grams of Rhizoma Curcumae, 80 grams of Semen Citri Reticulatae, 80 grams of the Rhizoma Pinelliae, 100 grams of Radix Angelicae Sinensis, Herba Leonuri 80 Gram, 80 grams of Rhizoma Corydalis, 30 grams of Olibanum, 30 grams of Myrrha, 60 grams of Radix Glycyrrhizae, the Radix Paeoniae Alba 80, Radix Curcumae 80,80 grams of the Radix Astragali, PORIA from Yunnan of China 80, Caulis et Folium Sinapis albee Son 80,80 grams of Semen Vaccariae, 80 grams of Bombyx Batryticatus.
CN201610967691.1A 2016-11-01 2016-11-01 Traditional Chinese medicine composition capable of treating breast hyperplasia Withdrawn CN106362095A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610967691.1A CN106362095A (en) 2016-11-01 2016-11-01 Traditional Chinese medicine composition capable of treating breast hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610967691.1A CN106362095A (en) 2016-11-01 2016-11-01 Traditional Chinese medicine composition capable of treating breast hyperplasia

Publications (1)

Publication Number Publication Date
CN106362095A true CN106362095A (en) 2017-02-01

Family

ID=57894053

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610967691.1A Withdrawn CN106362095A (en) 2016-11-01 2016-11-01 Traditional Chinese medicine composition capable of treating breast hyperplasia

Country Status (1)

Country Link
CN (1) CN106362095A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101049465A (en) * 2007-01-26 2007-10-10 郭晓华 Capsule of Chinese traditional medicine for treating cyclomastopathy
CN102526634A (en) * 2012-03-01 2012-07-04 王淑琳 Traditional Chinese medicine preparation for curing hyperplasia of mammary glands
CN104667178A (en) * 2015-02-08 2015-06-03 长沙佰顺生物科技有限公司 Medicine composition for treating hyperplasia of mammary glands
CN104840904A (en) * 2015-06-12 2015-08-19 李兰珍 Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN105194533A (en) * 2014-06-30 2015-12-30 黄钰 Oyster containing decoction for treating hyperplasia of mammary glands
CN105616990A (en) * 2016-01-27 2016-06-01 青岛云天生物技术有限公司 Medicine preparation for treating hyperplasia of mammary glands

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101049465A (en) * 2007-01-26 2007-10-10 郭晓华 Capsule of Chinese traditional medicine for treating cyclomastopathy
CN102526634A (en) * 2012-03-01 2012-07-04 王淑琳 Traditional Chinese medicine preparation for curing hyperplasia of mammary glands
CN105194533A (en) * 2014-06-30 2015-12-30 黄钰 Oyster containing decoction for treating hyperplasia of mammary glands
CN104667178A (en) * 2015-02-08 2015-06-03 长沙佰顺生物科技有限公司 Medicine composition for treating hyperplasia of mammary glands
CN104840904A (en) * 2015-06-12 2015-08-19 李兰珍 Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN105616990A (en) * 2016-01-27 2016-06-01 青岛云天生物技术有限公司 Medicine preparation for treating hyperplasia of mammary glands

Similar Documents

Publication Publication Date Title
CN101785844B (en) Traditional Chinese medicine combination and preparation method thereof for dysentery treatment
CN101766774B (en) Chinese medicine composite for treating duodenal ulcer and preparation method thereof
CN103381266B (en) Traditional Chinese medicine for treating nervous vomiting
CN102274466B (en) Chinese medicinal composition for treating gastritis
CN101773647B (en) Chinese medicine composition for treating duodenal carcinoma and preparation method thereof
CN104127567B (en) A kind of Chinese medicine composition for the treatment of diabetic peripheral neuropathy
CN102600432B (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN101874888B (en) Chinese medicinal composition for treating hiccup and preparation method thereof
CN101874890B (en) Chinese medicinal composition for treating epigastric upset and preparation method thereof
CN103142897B (en) Medicine used after esophageal achalasia operation
CN103520354B (en) Traditional Chinese medicine for treatment of blood-insufficiency type mammary gland hyperplasia and preparation method thereof
CN101757601B (en) Traditional Chinese medicine composite for treating esophageal rheumatism and preparation method thereof
CN102283993B (en) Traditional Chinese medicine composition for treating systemic lupus erythematosus
CN101850101B (en) Chinese medicinal composition for treating metrostaxis and preparation method thereof
CN1517115A (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN106362095A (en) Traditional Chinese medicine composition capable of treating breast hyperplasia
CN101085303A (en) Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN104587131A (en) Traditional Chinese medicinal composition for treating delayed menorrhea
CN103142898B (en) Preparation method of medicine used after esophageal achalasia operation
CN116350731B (en) Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof
CN102579787A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN106389598A (en) Traditional Chinese medicine composition for curing purpura
CN1994415B (en) Orally administered Chinese medicine for treating dysmenorrhea
CN106620121A (en) Traditional Chinese medicine composition for treating mammary gland hyperplasia caused by stagnation of qi due to depression of the liver
CN103191338B (en) Pharmaceutical composition for treating pediatric esophageal achalasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170201